Contraindicated use of 5-alpha-reductase inhibitors in women. [PDF]
Br J Clin Pharmacol, 2017 Item does not contain ...
Teichert M +2 more
europepmc +7 more sources
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality [PDF]
Urology, 2018 Ralph I Horwitz +2 more
exaly +2 more sources
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia [PDF]
Mayo Clinic Proceedings, 2016 Ralph I Horwitz +2 more
exaly +2 more sources
Clinics, 2018 OBJECTIVES: To assess the associations between preoperative treatment with 5-alpha reductase inhibitors and the risks of blood transfusion during transurethral resection of the prostate and blood clot evacuation or emergency department visits for ...
Ti-Yuan Yang +6 more
doaj +1 more source
Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia [PDF]
Investigative and Clinical Urology, 2020 Purpose: Preoperative use of 5α-reductase inhibitors (5ARIs) may cause fibrosis of the prostate tissue and reduce the efficiency of thulium laser surgery for treating benign prostate hyperplasia (BPH).
Jae Seung Chung +11 more
doaj +1 more source
Anatomic study of verumontanum during endoscopic surgeries in patients with benign prostatic hyperplasia [PDF]
International Brazilian Journal of Urology, 2021 Introduction and objective: To evaluate changes in verumontanum anatomy in patients with benign prostatic hyperplasia (BPH) who used 5-alpha reductase inhibitors (5-ARIs) and to propose an anatomical classification of the verumontanum.
Henrique Barbosa de Menezes +6 more
doaj +1 more source
The connection of 5-alpha reductase inhibitors to the development of depression
Biomedicine & Pharmacotherapy, 2021 Recent literature connects 5-alpha reductase inhibitors (5-ARIs) with neuropsychiatric adverse effects. Several clinical studies have indicated that former 5-ARIs users had a higher incidence of depressive symptoms and neuropsychiatric side effects than non-users.
Thiraphat, Saengmearnuparp +3 more
openaire +2 more sources
5 alpha-Reductase Inhibitors and Risk of Prostate Cancer Death
, 2020 Purpose: 5 alpha-Reductase inhibitors reduced the risk of prostate cancer in 25% in 2 randomized trials but increased the risk of Gleason 8-10 at biopsy. One explanation is that 5 alpha-reductase inhibitors induce morphological changes in prostate cancer
Robinson, David, +4 more
core +1 more source
Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors
, 1995 The present study describes the independent expression of the type 1 and 2 isoforms of human 5 alpha-reductase in the baculovirus-directed insect cell expression system and the selectivity of their inhibition.
Guirou, Olivier +5 more
core +3 more sources
Evaluation of Recent Trends in Treatment Patterns Among Men With Benign Prostatic Hyperplasia
American Journal of Men's Health, 2013 Although there is an abundance of evidence regarding clinical efficacy and safety of benign prostatic hyperplasia (BPH) treatment, real-world evidence is lacking for pharmacotherapy utilization and trends.
Eric J. Kruep PharmD, MS +2 more
doaj +1 more source